Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Oxygen Therapy in COPD at High Altitude
NCT03020212Completed
- Sponsor
- Fundación Neumológica Colombiana
- Start
- Feb 2016
- Primary completion
- Jan 2025
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Fundación Neumológica Colombiana. Primary endpoint: Development of pulmonary hypertension at 3 years. Started Feb 2016; status: completed.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03020212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020212.